A drug used to treat certain bone diseases shows promise for slowing the progression of a rare, painful genetic condition that causes excessive calcium buildup in the arteries, known as arterial calcification due to deficiency of CD73 (ACDC).

A research team led by Dr. Christopher Gibbons of Beth Israel Deaconess Medical Center has been working to identify accessible biomarkers that could help diagnose Parkinson’s disease and other neurodegenerative disorders.

NCI researchers developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person’s cancer will respond to a specific drug.

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD).

SARS-CoV-2, the virus that causes Covid-19, can damage the heart even without directly infecting the heart tissue.

Fenoprofen, a nonsteroidal anti-inflammatory drug (NSAID), successfully alleviated pain and inflammation in a rodent model of endometriosis.

Approximately 11% of 12th-grade students across the country reported past-year use of delta-8-tetrahydrocannabinol (delta-8-THC, or delta-8 for short), according to an analysis from the 2023 Monitoring the Future survey.

Common inherited genetic factors that predict cancer risk in the general population may also predict elevated risk of new cancers among childhood cancer survivors, according to a recent NCI study.

In a large clinical trial, a topical liquid, silver diamine fluoride (SDF), stopped tooth decay in young children.

Results from a large clinical trial funded by NIH show that an intervention for anxiety provided to pregnant women living in Pakistan significantly reduced the likelihood of the women developing moderate-to-severe anxiety, depression or both six weeks after birth.